Single cell metabolic phenome and genome via the ramanome technology platform: Precision medicine of infectious diseases at the ultimate precision?

iLABMED Pub Date : 2023-05-09 DOI:10.1002/ila2.12
Jian Xu, Jianzhong Zhang, Yingchun Xu, Yi-Wei Tang, Bo Ma, Yuzhang Wu
{"title":"Single cell metabolic phenome and genome via the ramanome technology platform: Precision medicine of infectious diseases at the ultimate precision?","authors":"Jian Xu,&nbsp;Jianzhong Zhang,&nbsp;Yingchun Xu,&nbsp;Yi-Wei Tang,&nbsp;Bo Ma,&nbsp;Yuzhang Wu","doi":"10.1002/ila2.12","DOIUrl":null,"url":null,"abstract":"<p>Due to the limitations of existing approaches, a rapid, sensitive, accurate, comprehensive, and generally applicable strategy to diagnose and treat bacterial and fungal infections remains a major challenge. Here, based on the ramanome technology platform, we propose a culture-free, one cell resolution, phenome-genome-combined strategy called <span>s</span>ingle-<span>c</span>ell <span>i</span>dentification, <span>v</span>iability and <span>v</span>itality tests and <span>s</span>ource tracking (SCIVVS). For each cell directly extracted from a clinical specimen, the fingerprint region of the D<sub>2</sub>O-probed single cell Raman spectrum (SCRS) enables species-level identification based on a reference SCRS database of pathogen species, whereas the C-D band accurately quantifies viability, metabolic vitality, phenotypic susceptibility to antimicrobials, and their intercellular heterogeneity. Moreover, to source track a cell, Raman-activated cell sorting followed by sequencing or cultivation proceeds, producinging an indexed, high coverage genome assembly or a pure culture from precisely one pathogenic cell. Finally, an integrated SCIVVS workflow that features automated profiling and sorting of metabolic and morphological phenomes can complete the entire process in only a few hours. Because it resolves heterogeneity for both the metabolic phenome and genome, targets functions, can be automated, and is orders-of-magnitude faster while cost-effective, SCIVVS is a new technological and data framework to diagnose and treat bacterial and fungal infections in various clinical and disease control settings.</p>","PeriodicalId":100656,"journal":{"name":"iLABMED","volume":"1 1","pages":"5-14"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ila2.12","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"iLABMED","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ila2.12","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Due to the limitations of existing approaches, a rapid, sensitive, accurate, comprehensive, and generally applicable strategy to diagnose and treat bacterial and fungal infections remains a major challenge. Here, based on the ramanome technology platform, we propose a culture-free, one cell resolution, phenome-genome-combined strategy called single-cell identification, viability and vitality tests and source tracking (SCIVVS). For each cell directly extracted from a clinical specimen, the fingerprint region of the D2O-probed single cell Raman spectrum (SCRS) enables species-level identification based on a reference SCRS database of pathogen species, whereas the C-D band accurately quantifies viability, metabolic vitality, phenotypic susceptibility to antimicrobials, and their intercellular heterogeneity. Moreover, to source track a cell, Raman-activated cell sorting followed by sequencing or cultivation proceeds, producinging an indexed, high coverage genome assembly or a pure culture from precisely one pathogenic cell. Finally, an integrated SCIVVS workflow that features automated profiling and sorting of metabolic and morphological phenomes can complete the entire process in only a few hours. Because it resolves heterogeneity for both the metabolic phenome and genome, targets functions, can be automated, and is orders-of-magnitude faster while cost-effective, SCIVVS is a new technological and data framework to diagnose and treat bacterial and fungal infections in various clinical and disease control settings.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
通过ramanome技术平台的单细胞代谢现象和基因组:传染病精准医学的终极精度?
由于现有方法的局限性,诊断和治疗细菌和真菌感染的快速、敏感、准确、全面和普遍适用的策略仍然是一个重大挑战。在这里,基于ramanome技术平台,我们提出了一种无培养、单细胞分辨率、现象基因组组合策略,称为单细胞鉴定、活力和活力测试以及来源跟踪(SCIVVS)。对于直接从临床标本中提取的每个细胞,D2O探测的单细胞拉曼光谱(SCRS)的指纹区能够基于病原体物种的参考SCRS数据库进行物种水平的鉴定,而C-D带准确地量化了生存能力、代谢活力、对抗菌剂的表型易感性及其细胞间异质性。此外,为了来源追踪细胞,进行拉曼激活的细胞分选,然后测序或培养,从一个致病细胞中产生索引的、高覆盖率的基因组组装或纯培养物。最后,一个集成的SCIVVS工作流程,以代谢和形态现象的自动分析和排序为特色,可以在几个小时内完成整个过程。由于它解决了代谢现象和基因组的异质性,靶向功能,可以自动化,速度快几个数量级,同时具有成本效益,SCIVVS是一种新的技术和数据框架,用于在各种临床和疾病控制环境中诊断和治疗细菌和真菌感染。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Issue Information Regulatory factors of ILC2 are therapeutic targets for lung inflammation Etiology, clinical features, and epidemiological analysis of diarrhea patients visiting a gastrointestinal clinic in a comprehensive hospital in Beijing, China, in 2023 A retrospective analysis of the relationship between dermatomyositis-associated interstitial lung disease and disease duration, age, arterial blood gas pH, and serum Cl− levels Ginkgo biloba active compounds can modulate the development of acute mountain sickness and ischemic stroke as discovered by network pharmacology and molecular docking
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1